Viewing StudyNCT00000820



Ignite Creation Date: 2024-05-05 @ 10:17 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00000820
Status: COMPLETED
Last Update Posted: 2021-10-28
First Post: 1999-11-02

Brief Title: A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy
Sponsor:
Organization: National Institute of Allergy and Infectious Diseases NIAID